Table 3.

IL15, sIL2-R and sTNF-R1 levels in PM/DM patients (in the first and second study time-point) and in control group

	Median (pg/ml)	P versus control/95% CI
IL-15 at 1st point	45 ± 188.02	0.038/17.8–47.4
IL-15 2nd point	28.53 ± 222.76	0.15/0.017–48.7
IL-15 control	28.5 ± 28.89	NA
sIL-2R at 1st point	317.2 ± 335.8	0.027/4.9–345
sIL-2R 2nd point	159.9 ± 563.8	0.4/0.001–231
sIL-2R control	144.3 ± 152.9	NA
sTNF-R1 at 1st point	328.8 ± 647.7	0.067/(−11)–286.5
sTNF-R1 2nd point	367.9 ± 724.0	0.041/9.81–213.9
sTNF-R1 control	205.9 ± 629.6	NA

Median level and standard deviation. P and 95%CI between patients and controls